SNX10 and acute lymphoblastic leukemia: Analysis revealed a significant reduction in SNX10 mRNA (Fig. 2A, P<0.01) and protein expression (Fig. 2B, P<0.05) in the patients with B-ALL, consistent with the results of bioinformatics analysis (Fig. 1E).